MK-0000-143

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-0000-143, covering 2015-01-22 to 2015-01-22. Get the full timeline:

Most recent: Clinical Trial Update: Positron Emission Tomography/Computed Tomography (PET/CT) in Relapsed Ovarian Cancer (MK-0000-143) [Phase 1]